Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

899 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience.
Morgagni P, Bencivenga M, Colciago E, Tringali D, Giacopuzzi S, Framarini M, Saragoni L, Mura G, Graziosi L, Marino E, Fumagalli Romario U, Baiocchi G, Moretti A, Rossi V, Verlato G. Morgagni P, et al. Among authors: moretti a. Clin Nucl Med. 2020 Mar;45(3):177-181. doi: 10.1097/RLU.0000000000002911. Clin Nucl Med. 2020. PMID: 31977470
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Caroli P, De Giorgi U, Scarpi E, Fantini L, Moretti A, Galassi R, Celli M, Conteduca V, Rossi L, Bianchi E, Paganelli G, Matteucci F. Caroli P, et al. Among authors: moretti a. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354. doi: 10.1007/s00259-017-3866-2. Epub 2017 Nov 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29110067 Clinical Trial.
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin.
Ambrosini V, Nanni C, Rubello D, Moretti A, Battista G, Castellucci P, Farsad M, Rampin L, Fiorentini G, Franchi R, Canini R, Fanti S. Ambrosini V, et al. Among authors: moretti a. Radiol Med. 2006 Dec;111(8):1146-55. doi: 10.1007/s11547-006-0112-6. Epub 2006 Dec 20. Radiol Med. 2006. PMID: 17171520 English, Italian.
Role of 18F-FDG PET for evaluating malignant pleural mesothelioma.
Nanni C, Castellucci P, Farsad M, Pinto C, Moretti A, Pettinato C, Marengo M, Boschi S, Franchi R, Martoni A, Monetti N, Fanti S. Nanni C, et al. Among authors: moretti a. Cancer Biother Radiopharm. 2004 Apr;19(2):149-54. doi: 10.1089/108497804323071913. Cancer Biother Radiopharm. 2004. PMID: 15186594 Clinical Trial.
18F-FDG PET early after radiotherapy in lymphoma patients.
Castellucci P, Zinzani P, Nanni C, Farsad M, Moretti A, Alinari L, Battista G, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Fanti S. Castellucci P, et al. Among authors: moretti a. Cancer Biother Radiopharm. 2004 Oct;19(5):606-12. doi: 10.1089/cbr.2004.19.606. Cancer Biother Radiopharm. 2004. PMID: 15650453
(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
De Giorgi U, Caroli P, Scarpi E, Conteduca V, Burgio SL, Menna C, Moretti A, Galassi R, Rossi L, Amadori D, Paganelli G, Matteucci F. De Giorgi U, et al. Among authors: moretti a. Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1276-83. doi: 10.1007/s00259-015-3042-5. Epub 2015 Mar 26. Eur J Nucl Med Mol Imaging. 2015. PMID: 25808631
Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results.
Matteucci F, Mezzenga E, Caroli P, Di Iorio V, Sarnelli A, Celli M, Fantini L, Moretti A, Galassi R, De Giorgi U, Paganelli G. Matteucci F, et al. Among authors: moretti a. Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2189-2194. doi: 10.1007/s00259-017-3791-4. Epub 2017 Aug 11. Eur J Nucl Med Mol Imaging. 2017. PMID: 28801787
899 results